In the latest quarter, 11 analysts provided ratings for PTC (NASDAQ:PTC), showcasing a mix of bullish and bearish perspectives. The table below provides a concise overview of recent ratings by ...

PTC (NASDAQ: PTC) will release its fiscal 2026 first quarter and on Wednesday, February 4th after the stock market closes. Senior management will host a live webcast and conference call to review the ...

PTC (PTC) is drawing investor attention after a recent stretch of weaker share performance, with the stock showing declines ...

Free access to Creo+, Onshape, Codebeamer+, and a startup package for Arena to enable startups to meet the speed, complexity, and compliance demands of modern aerospace and defense product development ...

Throughout the last three months, 6 analysts have evaluated PTC (NASDAQ:PTC), offering a diverse set of opinions from bullish to bearish. The following table provides a quick overview of their recent ...

Join us September 4–5, 2025, in Washington, D.C. Global technology leaders are set to convene at PTC’DC in Washington, D.C. to discuss advancements in AI, energy, and connectivity. PTC’DC brings ...

So if this idea of high risk and high reward doesn't suit, you might be more interested in profitable, growing companies, like PTC (NASDAQ:PTC). While profit isn't the sole metric that should be ...

PTC Therapeutics, Inc. (NASDAQ:PTCT) announced it has gained FDA approval for SEPHIENCE on Monday. “We are excited to have reached this important milestone for those affected by PKU,” said Matthew B.